Published in Circulation on November 09, 1999
Marfan's syndrome. Lancet (2005) 4.99
Embolic and bleeding events after modified Bentall procedure in selected patients. Heart (2006) 1.47
Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders. Circulation (2008) 1.18
Aortic insufficiency in a patient with Marfan syndrome after aortic root reconstruction with a tailored-sinus graft. Tex Heart Inst J (2003) 0.97
Aortic valve sparing operations: a review. Korean J Thorac Cardiovasc Surg (2012) 0.97
New use of teflon to reduce bleeding in modified bentall operation. Tex Heart Inst J (2008) 0.89
Marfan's syndrome and the heart. Arch Dis Child (2007) 0.83
Aortic valve sparing operations: outcomes at 20 years. Ann Cardiothorac Surg (2013) 0.77
Interventional treatment methods in patients with Marfan Syndrome. Images Paediatr Cardiol (2004) 0.75
Intraoperative conversion after surgical failure: an overlooked complication of aortic root replacement in Marfan patients? Tex Heart Inst J (2011) 0.75
The Marfan aortic root: time to refine surgical guidelines. Nat Clin Pract Cardiovasc Med (2009) 0.75
Overview of current surgical strategies for aortic disease in patients with Marfan syndrome. Surg Today (2015) 0.75
Personalised External Aortic Root Support (PEARS) Compared with Alternatives for People with Life-Threatening Genetically Determined Aneurysms of the Aortic Root. Diseases (2015) 0.75
The Delphi technique: a methodological discussion. J Adv Nurs (1994) 3.66
The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol (2000) 3.55
The Nottingham Health Profile as a measure of quality of life following combined heart and lung transplantation. J Epidemiol Community Health (1988) 3.35
Asymmetric redirection of flow through the heart. Nature (2000) 2.99
Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet (2007) 2.91
The real fate of pulmonary arteries after bidirectional superior cavopulmonary anastomosis: is there a need for concern? Cardiol Young (1999) 2.68
The human myocardial two-dimensional gel protein database: update 1994. Electrophoresis (1994) 2.57
Sources and types of referral to a haematology department. Health Trends (1992) 2.48
Anatomic correction of the syndrome of prolapsing right coronary aortic cusp, dilatation of the sinus of Valsalva, and ventricular septal defect. J Thorac Cardiovasc Surg (1997) 2.40
Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. Am J Hum Genet (1998) 2.31
Estrogen hits the surface. Nat Med (1999) 2.24
Spatiotemporal relation between gap junctions and fascia adherens junctions during postnatal development of human ventricular myocardium. Circulation (1994) 2.21
5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries. Cardiovasc Res (1990) 2.16
Altered connexin expression in human congestive heart failure. J Mol Cell Cardiol (2001) 2.15
Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet (1990) 2.04
Localization of a locus (GLC1B) for adult-onset primary open angle glaucoma to the 2cen-q13 region. Genomics (1996) 1.99
Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet (1996) 1.95
Late results of a valve-preserving operation in patients with aneurysms of the ascending aorta and root. J Thorac Cardiovasc Surg (1998) 1.94
Heart-lung transplantation for cystic fibrosis and subsequent domino heart transplantation. J Heart Transplant (1990) 1.84
Localization of the fourth locus (GLC1E) for adult-onset primary open-angle glaucoma to the 10p15-p14 region. Am J Hum Genet (1998) 1.82
Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans. Circulation (1998) 1.79
Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. J Am Coll Cardiol (1993) 1.77
Influence of anatomic correction for transposition of the great arteries on myocardial perfusion: radionuclide imaging with technetium-99m 2-methoxy isobutyl isonitrile. J Am Coll Cardiol (1994) 1.68
Anomalous origin of the left coronary artery from the anterior aortic sinus: a potential cause of sudden death. Anatomic characterization and surgical treatment. J Thorac Cardiovasc Surg (1981) 1.62
Cyclin-dependent kinase inhibitor expression in human heart failure. A comparison with fetal development. Eur Heart J (1999) 1.60
Successful double-lung transplantation with direct bronchial artery revascularization. Ann Thorac Surg (1993) 1.60
Variations in DNA methylation during mouse cell differentiation in vivo and in vitro. Proc Natl Acad Sci U S A (1984) 1.59
Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis. Clin Exp Immunol (1975) 1.59
Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation (2001) 1.56
Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching. Lancet (1995) 1.55
Pregnancy outcomes in urban aboriginal women. Med J Aust (1996) 1.54
Two mutations in Marfan syndrome resulting in truncated fibrillin polypeptides. Proc Natl Acad Sci U S A (1992) 1.54
High molecular weight kininogen deficiency: a patient who underwent cardiac surgery. Thromb Haemost (2001) 1.52
Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation (2001) 1.52
Specialist surgery in the developing world: luxury or necessity? Anaesthesia (2007) 1.52
Anatomy of the coronary arteries in transposition of the great arteries and methods for their transfer in anatomical correction. Thorax (1978) 1.51
Anatomy of the muscular subpulmonary infundibulum with regard to the Ross procedure. Ann Thorac Surg (2000) 1.51
Endothelial function of human gastroepiploic artery. Implications for its use as a bypass graft. J Thorac Cardiovasc Surg (1991) 1.50
Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation (2001) 1.46
Left atrial tamponade. Thorax (1966) 1.45
Immunocytochemical changes suggestive of damage to endothelial cells during rejection of human cardiac allografts. Transplantation (1990) 1.43
Heterotopic cardiac transplantation in infants and children. J Thorac Cardiovasc Surg (1997) 1.43
Valve interstitial cells induce donor-specific T-cell anergy. J Thorac Cardiovasc Surg (2001) 1.43
Development of an opiate-based anaesthetic technique for use in dogs with cardiomyopathy. Vet Rec (1991) 1.42
Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography. J Am Coll Cardiol (1997) 1.42
Unrecognized dyslipoproteinemia in United Kingdom families recruited to a genetic register because of unexplained coronary heart disease. J Lab Clin Med (1994) 1.42
Naive neutrophils and xenotransplantation. Lancet (1996) 1.41
Two-stage operation for anatomical correction of transposition of the great arteries with intact interventricular septum. Lancet (1977) 1.41
Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands. J Med Genet (2008) 1.41
Intermediate-term results of heart-lung transplantation for cystic fibrosis. Lancet (1992) 1.40
Retransplantation in heart-lung recipients with obliterative bronchiolitis. J Thorac Cardiovasc Surg (1994) 1.39
Magnetic resonance characterization of pulmonary arterial blood flow after single lung transplantation. J Thorac Cardiovasc Surg (1991) 1.38
Gianturco self-expanding metallic stents in treatment of tracheobronchial stenosis after single lung and heart and lung transplantation. Eur J Cardiothorac Surg (1991) 1.38
Dipyridamole vasodilator response after human orthotopic heart transplantation: quantification by oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol (1992) 1.38
A novel mutation of the fibrillin gene causing ectopia lentis. Genomics (1994) 1.36
End-stage dilated cardiomyopathy. Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation (1989) 1.36
Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest (1996) 1.35
Marfan syndrome: no evidence for heterogeneity in different populations, and more precise mapping of the gene. Am J Hum Genet (1991) 1.35
Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arterioscler Thromb Vasc Biol (1999) 1.35
Non-invasive mechanical ventilation for cystic fibrosis patients--a potential bridge to transplantation. Eur Respir J (1991) 1.35
Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J Pathol (1998) 1.34
Role of potassium channels in bronchodilator responses in human airways. Am Rev Respir Dis (1992) 1.33
A new technique for replacement of the mitral valve by a semilur valve homograft. J Thorac Cardiovasc Surg (1969) 1.30
Focus groups as a tool for critical social research in nurse education. Nurse Educ Today (2001) 1.26
Application of cereals and cereal components in functional foods: a review. Int J Food Microbiol (2002) 1.26
Hematoma of the interatrial septum with heart block secondary to dissecting aneurysm of the aorta. A clinicopathologic entity. Circulation (1972) 1.26
Anatomical correction of complete transposition of the great arteries and ventricular septal defect in infancy. Br Med J (1976) 1.25
Opening and closing characteristics of the aortic valve after different types of valve-preserving surgery. Circulation (1999) 1.24
Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type. Br J Pharmacol (1997) 1.24
Suppression of experimental allergic encephalomyelitis in Rhesus monkeys by a synthetic basic copolymer. Clin Immunol Immunopathol (1974) 1.24
Candida endocarditis after heart surgery. Thorax (1968) 1.23
Mapping of primary congenital lymphedema to the 5q35.3 region. Am J Hum Genet (1999) 1.21
Cardiovascular collapse after verapamil in supraventricular tachycardia. Arch Dis Child (1987) 1.20
Cardiorespiratory responses to exercise training after orthotopic cardiac transplantation. Circulation (1988) 1.19
Regulation of sigma S degradation in Salmonella enterica var typhimurium: in vivo interactions between sigma S, the response regulator MviA(RssB) and ClpX. J Mol Microbiol Biotechnol (2000) 1.19
A new missense mutation of fibrillin in a patient with Marfan syndrome. J Med Genet (1994) 1.19
Familial persistent ductus arteriosus. Arch Dis Child (1986) 1.19
Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation (1996) 1.18
Aortic homograft replacement of the mitral valve in sickle cell trait. J Thorac Cardiovasc Surg (1970) 1.18
Troponin I gene expression during human cardiac development and in end-stage heart failure. Circ Res (1993) 1.18
In vivo and in vitro immunological cross-reactions between basic encephalitogen and synthetic basic polypeptides capable of suppressing experimental allergic encephalomyelitis. Eur J Immunol (1973) 1.17
Incidence and clinical management of life-threatening left ventricular assist device failure. J Heart Lung Transplant (2004) 1.17
Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro. J Clin Invest (1993) 1.17
Suppression by several synthetic polypeptides of experimental allergic encephalomyelitis induced in guinea pigs and rabbits with bovine and human basic encephalitogen. Eur J Immunol (1973) 1.17
Immunohistochemical demonstration of human cardiac innervation before and after transplantation. Circ Res (1990) 1.16
Heat shock protein 70 gene transfection protects mitochondrial and ventricular function against ischemia-reperfusion injury. Circulation (2001) 1.15
Improving door to needle times with nurse initiated thrombolysis. Heart (2000) 1.15
Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation. J Chromatogr (1990) 1.15
Cardiovascular effects of intravenous salbutamol after open heart operations. Lancet (1973) 1.15
Isolation and characterization of the human cardiac troponin I gene (TNNI3). Genomics (1996) 1.14
Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection. Circulation (2000) 1.14
Vascular endothelial growth factor release following coronary artery bypass surgery: extracorporeal circulation versus 'beating heart' surgery. Eur Heart J (2000) 1.14
Is buscopan effective in meat bolus obstruction? Clin Otolaryngol (2005) 1.14